(Q44511627)

3 December 2017

title

Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice (English)

1 reference

3 December 2017

1 reference

angiogenesis inhibitor

1 reference

Bergers G

1

1 reference

3 December 2017

Hanahan D

series ordinal

2

1 reference

3 December 2017

publication date

1 January 2002

1 reference

Cold Spring Harbor Symposia on Quantitative Biology

3 December 2017

published in

1 reference

3 December 2017

volume

67

1 reference

3 December 2017

page(s)

293-300

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2002.67.293

21 January 2018

Identifiers

DOI

10.1101/SQB.2002.67.293

1 reference

3 December 2017

1 reference